The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Novel prognostic staging system for patients with de novo metastatic breast cancer: A real-world experience.
 
Ibrahim Khamees
No Relationships to Disclose
 
Himil Mahadevia
No Relationships to Disclose
 
Kensey Gosch
No Relationships to Disclose
 
Parth Sharma
No Relationships to Disclose
 
Simran Chandra
No Relationships to Disclose
 
Kelly C. Gast
No Relationships to Disclose
 
Timothy J. Pluard
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Carrick Therapeutics; Daiichi Sankyo/Astra Zeneca; DualityBio; Gilead Sciences; Jazz Pharmaceuticals; Kestrel Therapeutics; Merck; Novartis; Pfizer; Scorpion Therapeutics; Seagen; Sermonix Pharmaceuticals; Stemline Therapeutics
Speakers' Bureau - AstraZeneca; Gilead Sciences; SeaGen; Stemline Therapeutics
Research Funding - Arvinas; AstraZeneca/Daiichi Sankyo (Inst); Dantari (Inst); G1 Therapeutics (Inst); H3 Biomedicine (Inst); HiberCell (Inst); Novartis; Novartis; Olema Pharmaceuticals (Inst); Orinove (Inst); Pfizer (Inst); Sanofi (Inst); Scorpion Therapeutics; Seagen (Inst); Zymeworks (Inst)
 
Whitney L. Hensing
No Relationships to Disclose